Cargando…

Targeting SARS-CoV-2 RNA-dependent RNA polymerase: An in silico drug repurposing for COVID-19

Background: The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), took more lives than combined epidemics of SARS, MERS, H1N1, and Ebola. Currently, the prevention and control of spread are the goals in COVID-19 management as there...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baby, Krishnaprasad, Maity, Swastika, Mehta, Chetan H., Suresh, Akhil, Nayak, Usha Y., Nayak, Yogendra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	F1000 Research Limited 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7610171/ https://www.ncbi.nlm.nih.gov/pubmed/33204411 http://dx.doi.org/10.12688/f1000research.26359.1

Ejemplares similares

SARS-CoV-2 entry inhibitors by dual targeting TMPRSS2 and ACE2: An in silico drug repurposing study
por: Baby, Krishnaprasad, et al.
Publicado: (2021)

Targeting SARS-CoV-2 Main Protease: A Computational Drug Repurposing Study
por: Baby, Krishnaprasad, et al.
Publicado: (2021)

Computational drug repurposing of Akt-1 allosteric inhibitors for non-small cell lung cancer
por: Baby, Krishnaprasad, et al.
Publicado: (2023)

Thalidomide interaction with inflammation in idiopathic pulmonary fibrosis
por: Dsouza, Nikitha Naomi, et al.
Publicado: (2023)

Multi-Targeting Approach in Selection of Potential Molecule for COVID-19 Treatment
por: Velagacherla, Varalakshmi, et al.
Publicado: (2023)

Repurposing nonnucleoside antivirals against SARS-CoV2 NSP12 (RNA dependent RNA polymerase): In silico-molecular insight
por: Begum, Feroza, et al.
Publicado: (2021)

SARS-CoV-2 RNA Dependent RNA polymerase (RdRp) – A drug repurposing study
por: Ahmad, Jamshaid, et al.
Publicado: (2020)

Repurposing of potential antiviral drugs against RNA-dependent RNA polymerase of SARS-CoV-2 by computational approach
por: Gangadharan, Sivakumar, et al.
Publicado: (2022)

Molecular docking, binding mode analysis, molecular dynamics, and prediction of ADMET/toxicity properties of selective potential antiviral agents against SARS-CoV-2 main protease: an effort toward drug repurposing to combat COVID-19
por: Rai, Himanshu, et al.
Publicado: (2021)

In silico evaluation of potential intervention against SARS-CoV-2 RNA-dependent RNA polymerase
por: Kapoor, Shreya, et al.
Publicado: (2023)

Repurposing antiviral drugs against the human monkeypox virus DNA-dependent RNA polymerase; in silico perspective
por: Abduljalil, Jameel M., et al.
Publicado: (2022)

In silico identification of promising inhibitor against RNA-dependent RNA polymerase target of SARS-CoV-2
por: Singh, Pushpendra, et al.
Publicado: (2021)

Novel adenosine derivatives against SARS-CoV-2 RNA-dependent RNA polymerase: an in silico perspective
por: Sonousi, Amr, et al.
Publicado: (2021)

Repurposing FDA-approved drugs cetilistat, abiraterone, diiodohydroxyquinoline, bexarotene, and remdesivir as potential inhibitors against RNA dependent RNA polymerase of SARS-CoV-2: A comparative in silico perspective
por: Shahabadi, Nahid, et al.
Publicado: (2023)

Advances in targeting EGFR allosteric site as anti-NSCLC therapy to overcome the drug resistance
por: Maity, Swastika, et al.
Publicado: (2020)

Potential of turmeric-derived compounds against RNA‐dependent RNA polymerase of SARS‐CoV‐2: An in-silico approach
por: Singh, Rahul, et al.
Publicado: (2021)

In silico analysis of RNA-dependent RNA polymerase of the SARS-CoV-2 and therapeutic potential of existing antiviral drugs
por: Mondal, Sunil Kanti, et al.
Publicado: (2021)

Prediction of potential inhibitors for RNA-dependent RNA polymerase of SARS-CoV-2 using comprehensive drug repurposing and molecular docking approach
por: Parvez, Md. Sorwer Alam, et al.
Publicado: (2020)

Alkaloids and flavonoids from African phytochemicals as potential inhibitors of SARS-Cov-2 RNA-dependent RNA polymerase: an in silico perspective
por: Ogunyemi, Oludare M, et al.
Publicado: (2020)

Drummondin E and Flinderole B are potential inhibitors of RNA-dependent RNA polymerase of SARS-CoV-2: an in silico study
por: Akhtar, Nahid, et al.
Publicado: (2022)

The anti-HCV, Sofosbuvir, versus the anti-EBOV Remdesivir against SARS-CoV-2 RNA dependent RNA polymerase in silico
por: Elfiky, Abdo A., et al.
Publicado: (2021)

Identification of SARS-CoV-2 RNA-dependent RNA polymerase inhibitors from the major phytochemicals of Nigella sativa: An in silico approach
por: Mir, Shabir Ahmad, et al.
Publicado: (2022)

An in-silico glimpse into the pH dependent structural changes of T7 RNA polymerase: a protein with simplicity
por: Borkotoky, Subhomoi, et al.
Publicado: (2017)

Repurposing FDA-approved phytomedicines, natural products, antivirals and cell protectives against SARS-CoV-2 (COVID-19) RNA-dependent RNA polymerase
por: Kandeel, Mahmoud, et al.
Publicado: (2020)

Drug repurposing against main protease and RNA-dependent RNA polymerase of SARS-CoV-2 using molecular docking, MM-GBSA calculations and molecular dynamics
por: Mohammed, Ahmed O., et al.
Publicado: (2022)

RNA-dependent RNA polymerase (RdRp) inhibitors: The current landscape and repurposing for the COVID-19 pandemic
por: Tian, Lei, et al.
Publicado: (2021)

Mechanism of reaction of RNA-dependent RNA polymerase from SARS-CoV-2
por: Aranda, Juan, et al.
Publicado: (2022)

Baicalein and Baicalin Inhibit SARS-CoV-2 RNA-Dependent-RNA Polymerase
por: Zandi, Keivan, et al.
Publicado: (2021)

In silico studies of selected multi-drug targeting against 3CLpro and nsp12 RNA-dependent RNA-polymerase proteins of SARS-CoV-2 and SARS-CoV
por: Udofia, Inemesit A., et al.
Publicado: (2021)

Raltegravir, Indinavir, Tipranavir, Dolutegravir, and Etravirine against main protease and RNA-dependent RNA polymerase of SARS-CoV-2: A molecular docking and drug repurposing approach
por: Indu, Purushothaman, et al.
Publicado: (2020)

Insight into the Hantaan virus RNA-dependent RNA polymerase inhibition using in-silico approaches
por: Faisal, Shah, et al.
Publicado: (2022)

Computationally repurposed drugs and natural products against RNA dependent RNA polymerase as potential COVID-19 therapies
por: Piplani, Sakshi, et al.
Publicado: (2021)

Structure of the SARS-CoV-2 RNA-dependent RNA polymerase in the presence of favipiravir-RTP
por: Naydenova, Katerina, et al.
Publicado: (2021)

Inhibition of the RNA-dependent RNA Polymerase of the SARS-CoV-2 by Short Peptide Inhibitors
por: Pant, Suyash, et al.
Publicado: (2021)

Single molecule activity assay for SARS-CoV-2 RNA dependent RNA polymerase
por: Chung, SangYoon, et al.
Publicado: (2022)

Electron Density Analysis of SARS-CoV-2 RNA-Dependent RNA Polymerase Complexes
por: Palko, Nadezhda, et al.
Publicado: (2021)

Screening of potent drug inhibitors against SARS-CoV-2 RNA polymerase: an in silico approach
por: Singh, Sanjay Kumar, et al.
Publicado: (2021)

Identification of novel SARS-CoV-2 RNA dependent RNA polymerase (RdRp) inhibitors: From in silico screening to experimentally validated inhibitory activity
por: Uengwetwanit, Tanaporn, et al.
Publicado: (2022)

Polyphenol-based targeted therapy for oral submucous fibrosis
por: Mehta, Chetan Hasmukh, et al.
Publicado: (2023)

In Silico Identification and In Vitro Validation of Repurposed Compounds Targeting the RSV Polymerase
por: Xu, Eric, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8s8krkifv6jhkljea8q7ghel8i